Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
AOP Health
AOP Health
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Besremi
Ropeginterferon alfa-2b
2019-02-15
Polycythemia vera
Sugammadex amomed
Sugammadex
2023-01-10
2026
Neuromuscular blockade
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ropeginterferon alfa-2b
hepatitis b
,
chronic hepatitis
,
healthy volunteers/patients
,
chronic hepatitis d
,
myeloid leukemia chronic-phase
,
hepatitis
,
hepatitis a
,
hepatitis d
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
coinfection
,
primary myelofibrosis
,
essential thrombocythemia
,
thrombocytosis
,
chronic hepatitis b
,
hepatitis c
,
chronic hepatitis c
,
infections
,
communicable diseases
,
leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
covid-19
,
polycythemia
,
polycythemia vera
,
myeloproliferative disorders
,
herpesviridae infections
,
splenomegaly
Landiolol
healthy volunteers/patients
,
pharmacokinetics
Benzocaine
constipation
,
pure red-cell aplasia
,
alzheimer disease
,
anemia
,
chronic kidney failure
,
renal insufficiency
,
chronic renal insufficiency
,
kidney diseases
,
hypertriglyceridemia
,
syndrome
,
peptic esophagitis
,
esophagitis
,
myoclonic epilepsies
,
lennox gastaut syndrome
,
hypertension
,
ischemic stroke
,
stroke
,
ischemia
,
hyperlipidemias
,
crohn disease
,
hyperlipoproteinemias
Iron dextran
pulmonary arterial hypertension
,
eisenmenger complex
Tezosentan
hypertension
,
pulmonary arterial hypertension
,
familial primary pulmonary hypertension
Alfacalcidol
melanoma
,
healthy volunteers/patients
,
herpes zoster
,
chickenpox
,
immunosenescence
,
renal cell carcinoma
,
carcinoma
,
osteosarcoma
,
prostatic neoplasms
,
sleep initiation and maintenance disorders
,
sleep wake disorders
,
dyssomnias
,
mental disorders
,
allergic rhinitis
,
rhinitis
,
parasomnias
,
intrinsic sleep disorders
,
allergic rhinitis seasonal
,
allergic rhinitis perennial
,
prostatic hyperplasia
,
hyperplasia
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
chronic hepatitis
,
hepatitis a
Albinterferon alfa-2b
hepatitis
,
hepatitis a
,
hepatitis c
,
chronic hepatitis c
,
hepatitis b
,
chronic hepatitis b
,
chronic hepatitis
,
melanoma
LANCOVUTIDE
healthy volunteers/patients
,
fibrosis
,
cystic fibrosis
Nepidermin
hypercholesterolemia
,
hyperlipoproteinemia type ii
,
homozygous familial hypercholesterolemia
Retinol
iron-deficiency anemia
,
iron deficiencies
Ldla202
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use